A Note from Neal- Webinar Series: Progesterone for Women Part 4
A Note from Neal- Webinar Series: Progesterone for Women Part 4- What You Must Document Before Prescribing Micronized Progesterone by Neal Rouzier, MD February 2024 Cancer Newsletter – University of
Progesterone in Women #2- What You Must Know and Document Before Prescribing Menopausal Hormones
What You Must Know and Document Before Prescribing Menopausal Hormones by Neal Rouzier, MD Safety of P4 vs Progestin A recent review article published in JAMA made the distinction between
Progesterone in Women- What You Must Know and Document Before Prescribing Menopausal Hormones (Part 1)
Progesterone in Women- What You Must Know and Document Before Prescribing Menopausal Hormones (Part 1) by Neal Rouzier, MD Unfortunately, I cannot cover every paper and every concept of every
Testosterone for Women – The Final Chapter
Testosterone for Women- The Final Chapter by Neal Rouzier, MD June 2023 Testosterone in Women does not Stimulate Breast or Uterine Tissue Just when I thought that the April webinar
Testosterone for Women – The Most Important Webinar and Testosterone Study to Date
Testosterone for Women- The Most Important Webinar and Testosterone Study to Date by Neal Rouzier, MD April 2023 April’s webinar will be the last in the series of webinars addressing
Testosterone for Women: Current AACE Guidelines vs What the Literature Says
Testosterone for Women: Current AACE Guidelines vs What the Literature Says by Neal Rouzier, MD In Testosterone for Women Part 1: The Evidence and Benefits No One Talks About, I
Testosterone for Men: Facts, Figures and Literature that you Should Know Before Prescribing Testosterone
Testosterone for Men: Facts, Figures and Literature that you Should Know Before Prescribing Testosterone by Neal Rouzier, MD The more articles that demonstrate the benefits of testosterone, the more there
Testing for Dementia and Successful Therapies After Diagnosis
Testing for Dementia and Successful Therapies After Diagnosis by Neal Rouzier, MD Alzheimer's Dementia Case Study Recently, I was asked to consult on a 70 y/o man who was diagnosed with
How Hormones are Disrupting the Oncology Industry
Why is there increased morbidity and mortality in those that don’t take ERT? This is simply because there is an increase in breast cancer recurrence in prior cancer survivors, around 350/10,000 women (that don’t take HRT). This does not mean, though, that taking estrogen increases the risk. However, those that do take BHRT do benefit from HRT despite the resistance from oncologists. The increase in breast cancer recurrence at baseline should not be extrapolated to what happens with treatment. In every study, treatment with estrogen decreases breast cancer risk. Observation at baseline does not prove causation. The most recent issue of JAMA proved that the only drug to decrease breast cancer mortality was estrogen! It was not a SERM or AI.